Industry

CANbridge-UMass Chan Medical School Gene Therapy Research Presented at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting

First Study from CANbridge UMass Collaboration Shows Novel Gene Therapy Holds Promise for Spinal Muscular Atrophy Clinical Applications BEIJING & CAMBRIDGE, Mass.–(BUSINESS WIRE)–CANbridge Pharmaceuticals Inc. (HKEX:1228), a leading China-based global biopharmaceutical company committed to the research, development and commercialization of transformative rare disease and rare oncology therapies, announced the presentation of the initial data from … [Read more…]

ASC Therapeutics, U Mass Medical School, and the Clinic for Special Children Announce Podium Presentation of Safety and Efficacy in Murine and Bovine Models for Novel Gene Therapy in Maple Syrup Urine Disease at the 25th ASGCT Meeting

First known bovine model used to demonstrate safety and efficacy in gene replacement therapy MSUD is a severe genetic disease with liver transplantation or dietary restriction as the only treatments currently available MILPITAS, Calif.–(BUSINESS WIRE)–#ASCCT22–ASC Therapeutics in partnership with the University of Massachusetts Medical School (UMMS) and the Clinic for Special Children (CSC), will present … [Read more…]

Quidel Announces Stockholder Approval of Ortho Acquisition and Business Combination

SAN DIEGO–(BUSINESS WIRE)–Quidel Corporation (Nasdaq: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that the previously announced acquisition of Ortho Clinical Diagnostics Holdings plc (“Ortho”) by Quidel and subsequent business combination were approved by Quidel’s stockholders at Quidel’s Special Meeting on May 16, 2022. Subject … [Read more…]

Perimeter Medical Imaging AI to Present at ROTH Canada Showcase Day

TORONTO & DALLAS–(BUSINESS WIRE)–Perimeter Medical Imaging AI, Inc. (TSX-V:PINK)(OTC:PYNKF) (FSE:4PC) (“Perimeter” or the “Company”), a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address high unmet medical needs, announced it will participate in investor meetings and host a company presentation at the ROTH Canada Showcase Day to be … [Read more…]

Alight to Participate in J.P. Morgan 50th Annual Global Technology, Media and Communications Conference

LINCOLNSHIRE, Ill.–(BUSINESS WIRE)–Alight (NYSE: ALIT) (the “Company”) today announced that Chief Executive Officer Stephan Scholl and Chief Financial Officer Katie Rooney will participate in a fireside chat at the J.P. Morgan 50th Annual Global Technology, Media and Communications Conference on Tuesday, May 24, 2022 at 11:30 AM ET. Additionally, the Company will participate in one-on-one … [Read more…]

Labcorp Launches First-of-its-kind At-home Collection Device for Diabetes Risk Testing

Consumers Can Access the Diabetes Risk Test Kit As Well As Other Health and Wellness Tests Through Labcorp OnDemand BURLINGTON, N.C.–(BUSINESS WIRE)–There is a new and convenient way for millions of individuals to assess whether they are at risk for developing diabetes. Labcorp (NYSE: LH), a leading global life sciences company, is making screening for … [Read more…]

Veracyte Announces New Data Reinforcing Percepta Nasal Swab Test’s Clinical Performance and Utility in Lung Cancer Risk Assessment

Findings Presented at ATS 2022 SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Veracyte, Inc. (Nasdaq: VCYT) today announced new data showing that its Percepta Nasal Swab test accurately assesses lung cancer risk among current and former smokers with lung nodules, regardless of their smoking history burden and whether they are considered high risk for lung cancer based on … [Read more…]

UroGen Highlights New Data Presented at AUA that Adds to the Evidence Supporting In-Office Nephrostomy Tube Administration of JELMYTO®, the only Non-Surgical, Kidney-Sparing Treatment for Adults with Low Grade Upper Tract Urothelial Cancer

— Multi-Center Retrospective Study was Presented at the 2022 American Urological Association Annual Meeting in New Orleans — NEW ORLEANS–(BUSINESS WIRE)–#AUA2022–UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to creating novel solutions that treat urothelial and specialty cancers, today highlights new data on real-world experience utilizing the antegrade approach via nephrostomy tube for administration … [Read more…]

Positive Physicians Insurance Company Announces That Lewis Sharps, MD Is Stepping Down as Chief Executive Officer, Board Appoints Michael Roque as Successor

BERWYN, Pa.–(BUSINESS WIRE)–Positive Physicians Insurance Company (PPIC), a leading medical professional liability insurer serving healthcare providers across 10 states, announced that Lewis Sharps, MD, founder of Positive Physicians Insurance Exchange in 2002 and having been a critical component of the company’s growth over the past 20 years, is stepping down from his position as Chief … [Read more…]

LAMEA Non-invasive Aesthetic Treatment Market to 2027 – Size, Share & Industry Trends Analysis Report – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “LAMEA Non-invasive Aesthetic Treatment Market Size, Share & Industry Trends Analysis Report By End-Use (MedSpa, Hospital/Surgery Center, Traditional Spa, and HCP Owned Clinic), By Procedure, By Country and Growth Forecast, 2021-2027” report has been added to ResearchAndMarkets.com’s offering. The Latin America, Middle East and Africa Non-invasive Aesthetic Treatment Market is expected to witness … [Read more…]